Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Gross Profit: 2010-2025

Historic Gross Profit for Niagen Bioscience (NAGE) over the last 14 years, with Sep 2025 value amounting to $21.9 million.

  • Niagen Bioscience's Gross Profit rose 35.02% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.7 million, marking a year-over-year increase of 41.47%. This contributed to the annual value of $61.6 million for FY2024, which is 21.28% up from last year.
  • Niagen Bioscience's Gross Profit amounted to $21.9 million in Q3 2025, which was up 8.41% from $20.2 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Gross Profit ranged from a high of $21.9 million in Q3 2025 and a low of $9.2 million during Q1 2021.
  • For the 3-year period, Niagen Bioscience's Gross Profit averaged around $15.8 million, with its median value being $13.7 million (2024).
  • As far as peak fluctuations go, Niagen Bioscience's Gross Profit declined by 7.10% in 2022, and later spiked by 47.71% in 2025.
  • Over the past 5 years, Niagen Bioscience's Gross Profit (Quarterly) stood at $10.9 million in 2021, then climbed by 10.56% to $12.0 million in 2022, then rose by 7.66% to $12.9 million in 2023, then soared by 40.66% to $18.2 million in 2024, then soared by 35.02% to $21.9 million in 2025.
  • Its Gross Profit stands at $21.9 million for Q3 2025, versus $20.2 million for Q2 2025 and $19.3 million for Q1 2025.